Jon Merz pointed us to this amazing piece on the funding of Iceland’s for-profit genomics company, DeCode, which has official authorization to conduct population-based genomics research using the health histories and gene samples from Icelanders. NIH is funding a study of the genetics of infectious disease and vaccine response, which would access genome-wide scans of Icelanders. But does funding from NIH, though, imply the Fed’s assent – or might anyway – to DeCode’s “presumed consent” model?
Labels: DeCode, for-profit genomics, genomics, Iceland, NIH, vaccines
